Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jun 1;15(11):3597-623.
doi: 10.1016/j.bmc.2007.03.041. Epub 2007 Mar 18.

Improved biochemical strategies for targeted delivery of taxoids

Thota Ganesh  1
Affiliations
Review

Improved biochemical strategies for targeted delivery of taxoids

Thota Ganesh. Bioorg Med Chem. .

Abstract

Paclitaxel (Taxol) and docetaxel (Taxotere) are very important anti-tumor drugs in clinical use for cancer. However, their clinical utility is limited due to systemic toxicity, low solubility and inactivity against drug resistant tumors. To improve chemotherapeutic levels of these drugs, it would be highly desirable to design strategies which bypass the above limitations. In this respect various prodrug and drug targeting strategies have been envisioned either to improve oral bioavailability or tumor specific delivery of taxoids. Abnormal properties of cancer cells with respect to normal cells have guided in designing of these protocols. This review article records the designed biochemical strategies and their biological efficacies as potential taxoid chemotherapeutics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation of prodrug and drug conjugate delivery to tumor cells.
Fig 2
Fig 2
Scheme 1
Scheme 1
Scheme 2
Scheme 2
Scheme 3
Scheme 3
Scheme 4
Scheme 4
Scheme 5
Scheme 5
Scheme 6
Scheme 6
Scheme 7
Scheme 7
Scheme 8
Scheme 8
Scheme 9
Scheme 9
Scheme 10
Scheme 10
Scheme 11
Scheme 11
Scheme 12
Scheme 12
Scheme 13
Scheme 13
Scheme 14
Scheme 14
Scheme 15
Scheme 15
Scheme 16
Scheme 16
Scheme 17
Scheme 17
Scheme 18
Scheme 18
Scheme 19
Scheme 19
Scheme 20
Scheme 20
Scheme 21
Scheme 21
See this image and copyright information in PMC

References

    1. Rowinsky EK. Ann Rev Med. 1997;48:353–374. - PubMed
    1. Crown J, O’Leary M. The Lancet. 2000;355:1176–1178. - PubMed

    1. For leading references see: Wang TH, Wang HS, Soong YK. Cancer. 2000;88:2619–2628.Blagosklonny MV, Fojo T. Int J Cancer. 1999;83:151–156.Jordan MA, Toso RJ, Thrower D, Wilson L. Proc Natl Acad Sci USA. 1993;90:9552–9556.Soger PK, Dobles M, Tournebize R, Hyman AA. Curr Opin Cell Biol. 1997;9:807–814.

    1. For seminal reports please see: Schiff PB, Fant J, Horwitz SB. Nature. 1979;277:665–667.Horwitz SB. Trends Pharmacol Sci. 1992;13:134–136.

    1. Brown DT. ch. 11. In: Itokawa H, Lee K-H, editors. Taxus: The Genus Taxus. Taylor and Francis; London: 2003. pp. 387–435.

Publication types

MeSH terms

LinkOut - more resources